Mitotic count can predict tamoxifen benefit in postmenopausal breast cancer patients while Ki67 score cannot by Karin Beelen, Mark Opdam, Tesa Severson, Rutger Koornstra, Andrew Vincent, Jelle Wesseling, Joyce Sanders, Jan Vermorken, Paul van Diest, Sabine Linn

Get full text